Results from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk, muscle-invasive bladder cancer are cancer-free following surgical removal of the bladder.
Novel Agent Promising as Add-On Epilepsy Treatment
A novel selective potassium channel opener appeared promising against focal-onset seizures when given atop other epilepsy medications, according to a phase IIb trial. Treatment with
October 10, 2023